185 related articles for article (PubMed ID: 21823118)
1. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells.
Ruscica M; Dozio E; Boghossian S; Bovo G; Martos Riaño V; Motta M; Magni P
Endocrinology; 2006 Mar; 147(3):1466-73. PubMed ID: 16339211
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y receptor interactions regulate its mitogenic activity.
Czarnecka M; Lu C; Pons J; Maheswaran I; Ciborowski P; Zhang L; Cheema A; Kitlinska J
Neuropeptides; 2019 Feb; 73():11-24. PubMed ID: 30503694
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
Tilan J; Kitlinska J
Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
[TBL] [Abstract][Full Text] [Related]
11. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
13. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
Guo H; Castro PA; Palmiter RD; Baraban SC
J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
[TBL] [Abstract][Full Text] [Related]
14. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC
Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
[TBL] [Abstract][Full Text] [Related]
16. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus.
Fetissov SO; Byrne LC; Hassani H; Ernfors P; Hökfelt T
J Comp Neurol; 2004 Mar; 470(3):256-65. PubMed ID: 14755515
[TBL] [Abstract][Full Text] [Related]
17. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y functions as a neuroproliferative factor.
Hansel DE; Eipper BA; Ronnett GV
Nature; 2001 Apr; 410(6831):940-4. PubMed ID: 11309620
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
[TBL] [Abstract][Full Text] [Related]
20. Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules.
Stanić D; Mulder J; Watanabe M; Hökfelt T
J Comp Neurol; 2011 May; 519(7):1219-57. PubMed ID: 21452195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
